Israel - hebraisk - Ministry of Health

gilco pharm ltd - כלל האוכלוסיה - "לשימוש במצבי עצירות, מיועד לשימוש לפני בדיקות רפואיות , לפני לידות ולניקוי המעי הגס לפני ניתוחים"

Israel - hebraisk - Ministry of Health

gilco pharm ltd. - כלל האוכלוסיה - לשימוש במצבי עצירות, מיועד לשימוש לפני בדיקות רפואיות , לפני לידות ולניקוי המעי הגס לפני ניתוחים

Israel - hebraisk - Ministry of Health

medicure technologies ltd - כלל האוכלוסיה - תמיסה סטרילית ללא חומר משמר להרטבה וסיכוך, לשיפור ההידרציה של משטח העין

Israel - hebraisk - Ministry of Health

natural line enosh el - כלל האוכלוסיה - מנורה אינפרא אדומה

Israel - hebraisk - Ministry of Health

vitamed ltd,binyamina - aciclovir 5 g / 100 g - ointment - antivirals - for local treatmet of viral infections and labial herpes simplex.

Israel - hebraisk - Ministry of Health

bristol - myers squibb, israel - atazanavir as sulfate - קפסולות - atazanavir as sulfate 200 mg - atazanavir - atazanavir - reyataz is indicated in combination with other antiretroviral agents for the treatment of hiv-1 infection.

Israel - hebraisk - Ministry of Health

pfizer pfe pharmaceuticals israel ltd - exemestane - טבליות מצופות - exemestane 25 mg - exemestane - exemestane - aromasin is indicated for the treatment of advanced breast cancer (abc) in women with natural or induced postmenopausal status whose disease has progressed following anti-oestrogen therapy alone. aromasin is also indicated for the treatment of postmenopausal women with abc whose disease has progressed following multiple hormonal therapies. aromasin is indicated for the adjuvant treatment of postmenopausal women with oestrogen receptor positive invasive early breas cancer following 2-3 years of initial adjuvant tamoxifen therapy.

Israel - hebraisk - Ministry of Health

אלדן ציוד אלקטרוני בע"מ - צוות טכני - in vitro diagnostic kits for the detection and quantification of viral/bacterial dna/or rna

Israel - hebraisk - Ministry of Health

glaxo smith kline (israel) ltd - diphtheria toxoid; filamentous haemagglutinin (fha); inactivated polio virus (ipv) type 1; inactivated polio virus (ipv) type 2; inactivated polio virus (ipv) type 3; pertactin (prn or 69 kda omp); pertussis toxoid vaccine; tetanus toxoid - תרחיף להזרקה - pertactin (prn or 69 kda omp) 2.5 mcg / 0.5 ml; diphtheria toxoid nlt 2 iu / 0.5 ml; tetanus toxoid nlt 20 iu / 0.5 ml; filamentous haemagglutinin (fha) 8 mcg / 0.5 ml; pertussis toxoid vaccine 8 mcg / 0.5 ml; inactivated polio virus (ipv) type 3 32 du / 0.5 ml; inactivated polio virus (ipv) type 1 40 du / 0.5 ml; inactivated polio virus (ipv) type 2 8 du / 0.5 ml - bacterial and viral vaccines, combined - for booster vaccination against diphtheria, tetanus and pertusis and poliomyelitis of individuals from the age of four years onwards. boostrix polio is not intended for primary immunisation. the administration of boostrix polio should be based on official recommendations.

Israel - hebraisk - Ministry of Health

gilead sciences israel ltd - sofosbuvir; velpatasvir; voxilaprevir - טבליות מצופות פילם - voxilaprevir 100 mg; velpatasvir 100 mg; sofosbuvir 400 mg - sofosbuvir, velpatasvir and voxilaprevir